Panel of Lecturers
The BBI Academic Board comprises more than 100 global leaders from the biotechnology and life sciences sectors, providing our candidates with unprecedented access to real-world expertise and strategic industry insights.
Technology Transfer, Early Stage Innovation & IP
Our experts in Technology Transfer and Early Stage Innovation combine experience from universities, research institutions, and international biotechnology companies. They have worked at the intersection of science and business, transforming academic discoveries into commercial ventures through strategic partnerships and cross-sector collaboration.
Their teaching and mentoring help participants understand how innovation ecosystems function around the world, from evaluating intellectual property and protecting scientific discoveries, to assessing potential candidates and structuring technology licensing agreements. By combining real-world case studies with strategic insight, they prepare students to bridge science, IP management, and enterprise, ensuring that innovation in life sciences can thrive sustainably in a global market.
Clare Jones
Head of R&D at Talisman Therapeutics, Cambridge, United Kingdom
Nicholas Duggan
Founder at Zuas, Dublin, Ireland
William Bains
Chief Scientific Officer at Five Alarm Bio Ltd, Cambridge, United Kingdom
David Parry-Smith
Head of Cellular Informatics at Wellcome Sanger Institute, Cambridge, United Kingdom
Tai-Ping Fan
Distinguished Professor of Northwest University, Xi’an, China
David McKinley
President at McKinley IP, Minnesota, USA
Kiri Granger
CSO at Monument Therapeutics, Cambridge, United kingdom
Bill Matthews
Consultant at Cambridge Enterprise, Cambridge, United Kingdom
Albert Barbera
Director of External Strategy at Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain
Richard Cumming
Technology Commercialisation Consultant at Ithaka Life Sciences, Oxfordshire, United Kingdom
Tiago Botelho
Senior TTO Business Development Manager at IRB Barcelona, Spain
Patrick Hooper
Innovation Scientist at Bactobio, London, United Kingdom
Sally Shorthose
IP & Life Sciences Partner at Bird & Bird and Jt Head International Regulatory Group, London, United Kingdom
Roxana Ispuro
Partner Patents and Tech Transfer at BC&B, cdmx, Mexico
Francesco Senatore
Director Business Development at Bio4Dreams , Siena, Italy
Corporate Finance and Venture Capital
Specialists in Corporate Finance and Venture Capital bring a powerful mix of financial strategy and scientific understanding. Many have founded, financed, or advised biotechnology and healthcare ventures internationally, offering a unique perspective on how investment decisions shape innovation and value creation.
Through interactive sessions and real-world examples, participants explore how to structure companies, attract investors, and plan long-term growth. The focus is on applying financial tools to global innovation challenges, understanding how capital flows, private equity, and venture funding drive the next generation of life science breakthroughs.
David D'Alton
Executive Chairman, Oyster Venture Partners, Brussels
Rupert Lewis
CEO at Oyster Venture Partners, Manchester, United Kingdom
Tom Mawhood
Business & Corporate Finance and Investment, Consultancy, Non Exec Director, Accountancy, Turnaround, Nottinghamshire, United Kingdom
Nicholas Draeger
Founder and Director at Cederberg GmbH, Basel area, Switzerland
Caroline Austin
Vice President, Head of Transactions, Business Development at AstraZeneca, Cambridge, UK
Shaun Grady
Chair at AstraZeneca UK, Cambridge, United Kingdom
Soyoung Park
General Partner at 1004 Venture Partners, California, United States
Guillem Laporta
Partner at Ysios Capital, Barcelona, Spain
Hakan Goker
Managing Director at M Ventures, Head of Biotechnology Investments, Amsterdam, The Netherlands
Mindy Daeschner
Managing Partner at Daeschner Consulting, London, UK
James Baillieu
Corporate Partner for Venture Capital & Life Sciences at Bird & Bird, London, United kingdom
Prashant Shah
CEO & co-founder o2h group, Company/Ecosystem Builder & Seed Investor, Cambridge, United Kingdom
Pedro Lopez
Managing Partner at FrissOn capital, Delaware, United States
Brent James
Investor, Life Sciences Business Mentor, Vancouver, Canada
Regulatory Affairs & Clinical Operations
Professionals in Regulatory Affairs and Clinical Operations bring extensive experience in navigating complex regulatory pathways and clinical development strategies across global healthcare systems. They have worked closely with leading agencies such as the FDA and EMA, while also supporting access in emerging and fast-developing markets.
Their work goes beyond compliance, focusing on how to design multinational clinical trials, align with regional frameworks, and enable efficient market entry. They also emphasize the role of global entrepreneurship and international alliances in accelerating innovation and ensuring that new therapies reach patients everywhere.
Julia Levy
Principal at IQVIA, London, United Kingdom
Tonicha Spencer
Head of UK Sales and Clinical Support at NuVision Biotherapies Ltd, London, United Kingdom
Matt Cooper
Executive Director, Oncology Strategy Lead at World Wide Clinical Trials, London, United Kingdom
Lauren Tang
Senior Business Development Consultant Health-Tech, Pharma, Med Devices and Clinical Trials, Crowthorne, England, UK
Ivana Poparic
Head of Life Sciences Cluster Development at MedCity, London, United Kingdom
Santiago Esteva
Head Clinical Trials Support Unit at Parc Taulí (I3PT) Research & Innovation Institute, Barcelona, Spain
Ben Holland
Co-founder and CTO at Antiverse, Cardiff, United Kingdom
Mark Treherne
Chair at Monument Therapeutics, Cambridge, United Kingdom
Mayra Mora
Digital Health Specialist - MedTech Consultant, cdmx, Mexico
Sheryl Caswell
Head of Development at Monument Therapeutics Ltd, Hemel Hempstead, United Kingdom
Patrick O'Brien
Senior Team Lead & Project Manager at QMENTA, Barcelona, Spain
Gill Langley
Expert on human-relevant techniques in health research and drug discovery in place of animal studies
Pooja Datt
Senior Research Manager at St. Mark's Hospital Foundation, Director & Founder at DynamIQ Limited, London, UK
View Profile
Biotechnology Based Companies & Entrepreneurship
Our contributors in Biotechnology and Entrepreneurship are founders and executives who have built and led successful ventures across the life sciences and healthcare industries. They bring real experience from launching startups, scaling internationally, and partnering across borders.
Through their sessions and mentoring, participants learn how to turn scientific ideas into viable global businesses. Combining strategic thinking with hands-on insight, they demonstrate how entrepreneurship, collaboration, and innovation drive growth and create meaningful impact across the biotechnology ecosystem.
Andrew Chapman
CEO/CSO and Co-founder Carbometrics, Bristol, United Kingdom
María Isabel Tabares
CEO at TresQuince S.A.S, Medellin, Colombia
Annastasiah Mudiwa
President & COO at Red Abbey Labs Maryland, United States
Jordi Martorell
CEO & Co-founder en Aortyx, Barcelona, Spain
Kjell-Inge Arnevig
Co-Founder & Partner at Norn Ventures, Bergen, Norway
Jenny Barnett
CEO at Monument Therapeutics, Cambridge, United Kingdom
Murat Tunaboylu
CEO at Antiverse, Cambridge, United Kingdom
Roland Kozlowski
Executive Chairman at OncoTherics Limited, London, United Kingdom
Mark Ramondt
Co-Founder at MultiplAI, London,en United Kingdom
Harrison Waid
Co-Founder at Succession, London, United Kingdom
Alan Palmer
CEO at Elixa MediScience, Cambridge, United Kingdom
Jason Mundin
Managing Director at Ubiquigent Ltd, Cambridge, United Kingdom
Business Development & Portfolio Management
Leaders in Business Development and Portfolio Management have negotiated partnerships, licensing deals, and acquisitions that shape the modern life sciences landscape. Their experience spans from early-stage collaborations to global product launches, reflecting a deep understanding of how innovation evolves across diverse markets.
They guide participants in identifying strategic opportunities, structuring deals, and managing portfolios that balance innovation, risk, and growth. With a global and cross-functional outlook, these experts empower students to develop the relationship-building and negotiation skills needed to advance innovation worldwide.
Lubor Gaal
Chief Financial Officer and Head of Business Development at Circio Holding ASA, Oslo, Norway
Martin Shiderov
Director of Business Development at MicroA, London, United kingdom
Andrea Burgos
Head of Alliance Management at NewAsmterdam Pharma, Amsterdam, The Netherlands
David Ricketts
Director, Business Development (CMO) at eTheRNA immunotherapies, Scotland, United Kingdom
William Hariri
Co-founder & CBO at Enterome, London, United Kingdom
Christian Suojanen
Christian Suojanen, CEO at Broadreach Global & Board Member at European Brain Foundation, Miami, US
Christopher Church
Head of Technology Search, Evaluation and Transactions, BD&L, AZ Biopharmaceuticals R&D at AstraZeneca, Cambridge, UK
Ashley Nagle
Chief Business Officer at Epsilogen Ltd, Strasbourg, Grand, France
Jason Brown
SVP Business Development at Evotec, Cambridge, United Kingdom
Hozefa Amijee
Business Development Executive at Cellesce, Cambridge, United Kingdom
Robin Owen
Head of Alliance Management and Integration at AstraZecenca, Northamptonshire, United Kingdom
Nicholas Clare
Vice President of Strategic Alliances at DefiniGEN, Cambridge, United Kingdom
Global Marketing & Medical Strategy
Professionals in Global Marketing and Medical Strategy have led international product launches and brand development for some of the world’s most recognized pharmaceutical and biotech companies. They understand how scientific evidence, market insight, and communication come together to shape global success.
Through real-world case studies, they reveal how multidisciplinary teams coordinate medical, regulatory, and marketing strategies for worldwide impact. Their guidance helps participants master the art of positioning innovation, connecting clinical value with patient needs and global market dynamics.
Ted Agne
President at Communications Strategy Group Inc, Boston, United States
Noel Ortiz
CEO & Co-founder at Tinkery, Barcelona, Spain
Yves Serroen
Biopharma Business Development Director at SOPHiA GENETICS, Zurich, Switzerland
Tracey Huddy
Senior Global Marketing Director and Commercial Leader, United Kingdom
Steven Dodsworth
Founder at DHV-NET, Molières, France
Gunter Wessels
Founder & Chief Revenue Officer (CRO) at LiquidSMARTS, Tennessee, United States
Chris Howie
Founder at Norn Ventures, London, United Kingdom
Susie Boyce
Global Head of project Management Centre of Excellence at NED, United Kingdom
Tim Sherwell
Head of New Supply Establishment and Strategy at AstraZeneca, Macclesfield, United Kingdom
Paul Rainey
Global Channel Partner Manager at Nonacus Ltd, Wells, United Kingdom
Market Access, Health Economics & Goverment Affairs
Experts in Market Access and Health Economics combine a deep understanding of healthcare systems, payer expectations, and the economics of innovation. They have helped shape strategies that ensure new therapies are both accessible and sustainable within diverse policy and funding environments.
Through practical analysis and discussion, they teach how early planning and health economics influence long-term success. Participants explore how to demonstrate value, design access strategies, and align science with social and economic priorities, preparing them to navigate the increasingly complex global landscape of healthcare innovation.
Sandrine Ruiz
Senior Market Access Manager at Immunocore, Barcelona, Spain
Ravi Chana
Executive Director, Diagnostics at ABHI (Association of British Healthtech Industries), London, UK
Martin Schuchdart
Executive Director - Pricing and Market Access at FIECON, Medellin, Colombia
Marie Chivers
Founder at Facilipharma, Great Hormead, United Kingdom
Harriet Fear
Director of Cambridge& and Chair of Cambridge Ahead, Cambridge, United Kingdom
Carmen Georgescu
Commercial Director at Astellas Pharma HBR, Hungary, Bulgaria and Romania
Ester Garrido
Associate Director Global Market Access at PTC Therapeutics, Inc. New York, United States
David Martorell
Busines Unit Director, former Regional Head of LatAm Affiliates at Ferrer, Barcelona, Spain
Marcel Bassil
CEO & Founder at MB Bioservices, Montreal, Canada.
Mark Stimpfig
Strategic Growth Advisor at Innovaud, UK & Switzerland
Jordi Aparici
HEOR & Pricing Market at Sanofi, Barcelona, Spain
Matthew Speers
Senior business leader in UK life sciences, London, United Kingdom
Leadership, Coaching & Global Team Management
Our professionals in Leadership and Coaching are senior executives and industry mentors who have led international teams across biotechnology, pharmaceuticals, and healthcare innovation. They bring deep experience in managing cross-functional, multicultural environments where scientific excellence and business strategy intersect.
In their sessions, participants explore what it means to lead in the global life sciences industry, from building high-performing teams and managing change to fostering innovation and purpose-driven leadership. Through evidence-based coaching and real-world examples, these experts help professionals strengthen their leadership style, inspire collaboration, and drive results in a connected, international industry.
Chris Williams
Managing Director at Questae Coaching & Consulting, London, United Kingdom
Berengere Toscano
Associate Director, Talent & Learning at IQVIA, Milan, Italy
Thomas Treherne
CEO & Founder at Innovis Search, Cambridge, United Kingdom
Fiona Nielsen
Launch Programme Director at Pioneer Group, London, United Kingdom
Louise Wood
Business Change Consultant at Agile Business Techniques, England, United Kingdom
Majid Islam
Principal Consultant, Executive Leader, Co-Founder: Alignment Cubed, Cambridge, United kingdom
Cathie Mackay
Executive and Leadership Coach, Non-Executive Director Health and Safety Executive, London, United Kingdom
Maurice Herring
Managing Director, Owner at Herring Partners, Cambridge, United Kingdom
Nick Pope
Managing Director at The Academy of High Performance Teams, Sidney, Australia
Suresh Chahwala
Director at Vascuras Ltd, London, United Kingdom
Roop Chandwani
CEO at Mazards, London, United Kingdom
Pete Harpum
Partner Europe & UK, GROWTHSQAPES, Professor of Management: Grenoble Ecole de Management, Director: Portitor Ltd, Santarém, Portugal